Tshuaj kho mob ntsws tshiab: Afatinib
Afatinib yog ib tug muaj zog, irreversible dual inhibitor ntawm tib neeg epidermal kev loj hlob yam receptor 2 (HER2) thiab epidermal loj hlob yam receptor (EGFR) tyrosine kinases. Thiab raws li kev tshawb fawb kho mob, afatinib yog qhov tsim nyog rau kev kho mob ntsws cancer thiab mob qog noj ntshav mis.
Cov tsos mob tshwm sim: thawj kab kev kho mob ntawm cov mob qog noj ntshav uas tsis yog me me hauv lub ntsws (NSCLC), HER2- mob qog noj ntshav siab zoo
Kev Siv: Siv tsawg kawg 1 teev ua ntej lossis 2 teev tom qab noj mov
Dosage: 40mg ib hnub ib zaug
Kev mob tshwm sim: Cov kev phiv tshwm sim feem ntau suav nrog raws plab, xeev siab, ua pob liab liab, proteinuria, kub siab, thiab anorexia asymptomatic QT prolongation.
Los ntawm txoj kev, Yog tias koj yog ib tus neeg siv, peb xav kom koj sab laj nrog koj tus kws kho mob ua ntej siv.
Yog tias koj muaj lwm yam kev nug lossis lus nug, thov hu rau peb dawb.
